How do you dose concurrent chemotherapy with once daily radiation for bladder preservation in urothelial carcinoma?

Topics: Radiation Oncology • Genitourinary Cancers • Bladder Cancer • Medical Oncology

The recommended concurrent chemotherapy regimens (cisplatin/paclitaxel and cisplatin/FU) in NCCN are based on BID fractionation of radiation as in RTOG/NRG trials 0233 and 0712. On what data do you base your bladder preservation regimen?

Answer from: Radiation Oncologist at Academic Institution

Two contemporary trials which used daily radiotherapy and concurrent chemotherapy are BC2001 and RTOG 0712 with concurrent chemotherapy schedules as below. Other regimens such as platinum alone have been reported on as well.BC2001: 5FU: 500mg/m²/d d1-5 & d16-20 MMC: 12mg/m&sup...

Comments

Radiation Oncologist at Dana-Farber Cancer Institute, Harvard Medical School
SWOG/NRG 1806, the currently accruing Phase III RC...

Answer from: Radiation Oncologist at Community Practice

There is data on 5FU (day 1 and 21) and MMC (day 1) and also weekly gemcitabine with once-a-day RT.

Related Questions